FindTrial
Sign In

Comparison of Sedation between Ramimazolam and propofol for Transesophageal Echocardiography: A Randomized Controlled Study

Comparison of Sedation between Ramimazolam and propofol for Transesophageal Echocardiography: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083397
Enrollment
Unknown
Registered
2024-04-23
Start date
2023-06-15
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transesophageal echocardiography

Interventions

RA:The loading dose is alfentanil 5 µg/kg+remimazolam 0.3mg/kg, slow intravenous injection
PA:The loading dose is alfentanil 5 µg/kg+propofol 2mg/kg, slow intravenous injection

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-70 years old; (2) ASA level I-III; (3) Agree to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Complex congenital heart disease, severe heart failure, malignant arrhythmia; (2) BMI>30; (3) Drug abuse or long-term use of psychotropic substances; (4) Drug allergy; (5) Unable to cooperate.

Design outcomes

Primary

MeasureTime frame
Hemodynamic index;—

Secondary

MeasureTime frame
nausea and vomiting;respiratory depression;Fluid replacement volume;Wake-up time;—

Countries

China

Contacts

Public ContactDongnan Hou

The Second Affiliated Hospital of Dalian Medical University

dongnanhouxy@163.com+86 177 0987 2323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026